Lee's Pharmaceutical Holdings Limited

OTCPK:LPCU.F Stock Report

Market Cap: US$111.5m

Lee's Pharmaceutical Holdings Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:LPCU.F Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
05 Jun 26BuyUS$11,026Wanee LeelalertsuphakunIndividual81,500US$0.14
04 Jun 26BuyUS$27,568Wanee LeelalertsuphakunIndividual200,000US$0.14
29 May 26BuyUS$5,613Wanee LeelalertsuphakunIndividual41,500US$0.14
28 May 26BuyUS$26,548Wanee LeelalertsuphakunIndividual200,000US$0.13
04 Sep 25SellUS$576,225GL Capital GroupCompany2,132,500US$0.27
02 Sep 25SellUS$565,754GL Capital GroupCompany2,528,500US$0.22
26 Aug 25SellUS$708,554GL Capital GroupCompany2,942,000US$0.24
21 Aug 25SellUS$1,325,650GL Capital GroupCompany5,004,000US$0.26
20 Aug 25SellUS$1,211,328GL Capital GroupCompany4,174,000US$0.29
18 Aug 25SellUS$1,263,659GL Capital GroupCompany4,790,000US$0.26
15 Aug 25SellUS$497,565GL Capital GroupCompany2,053,500US$0.24
14 Aug 25SellUS$842,799GL Capital GroupCompany3,397,000US$0.25
08 Aug 25SellUS$95,130Gortune International Investment Holding LimitedCompany435,000US$0.22
08 Aug 25SellUS$304,085GL Capital GroupCompany1,276,500US$0.24
07 Aug 25SellUS$479,975GL Capital GroupCompany1,993,500US$0.24
05 Aug 25SellUS$336,581GL Capital GroupCompany1,348,000US$0.25

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of LPCU.F?
Owner TypeNumber of SharesOwnership Percentage
VC/PE Firms29,500,0005.01%
Institutions41,348,2167.02%
Individual Insiders69,492,14111.8%
General Public206,843,54035.1%
Private Companies241,651,44641%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 22 shareholders own 64.87% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
19.4%
Huby Technology Limited
114,000,625US$21.6m0%no data
12%
Apta Finance S.A.
70,675,577US$13.4m0%no data
9.99%
Xiaoyi Li
58,815,266US$11.1m0%no data
5.01%
Panacea Venture Management Co., Ltd.
29,500,000US$5.6m0%6.69%
4.99%
Gortune International Investment Holding Limited
29,390,435US$5.6m0%no data
4.98%
UBS Asset Management AG
29,330,425US$5.6m0%no data
3.68%
Gl Healthcare Investment LP
21,680,488US$4.1m0%no data
1.45%
Wanee Leelalertsuphakun
8,556,000US$1.6m0%no data
1.02%
GL Capital Group
6,034,500US$1.1m0%0.43%
1%
Aptafin S.p.A.
5,904,321US$1.1m0%no data
0.85%
Dimensional Fund Advisors LP
5,004,411US$947.7k3.35%no data
0.14%
Siu Fong Lee
800,875US$151.7k0.11%no data
0.12%
American Century Investment Management Inc
682,000US$129.2k0%no data
0.088%
Yau Ching Chan
520,000US$98.5k0%no data
0.085%
Zuie-Chin Huang
500,000US$94.7k0%no data
0.051%
Wah Keung Tsim
300,000US$56.8k0%no data
0.023%
Acadian Asset Management LLC
134,169US$25.4k0%no data
0.015%
SEI Investments Company
86,110US$16.3k0%no data
0.0085%
Fidelity International Ltd
50,000US$9.5k0%no data
0.0032%
Broad Asset Management Co., Ltd
19,000US$3.6k0%0.01%
0.0013%
China Merchants Fund Management Company Ltd.
7,600US$1.4k0%no data
0%
Credit Suisse Group AG
1US$00%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/02/17 00:36
End of Day Share Price 2025/11/20 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Lee's Pharmaceutical Holdings Limited is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Chu WangCitigroup Inc
Jun Zhou LiEverbright Securities Co. Ltd.
Yue-Kwong LuiJefferies LLC